| scholarly article | Q13442814 |
| P50 | author | Hitoshi Ando | Q60313852 |
| P2093 | author name string | Tsuguhito Ota | |
| Shuichi Kaneko | |||
| Toshinari Takamura | |||
| Hiroshi Akahori | |||
| Muneyoshi Torita | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | 514-521 | |
| P577 | publication date | 2005-04-27 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression | |
| P478 | volume | 314 |
| Q37887401 | Antifibrotic treatment and other new strategies for improving renal outcomes |
| Q37964276 | New options and perspectives for proteinuria management after kidney transplantation. |
| Q36921222 | Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations |
| Q26864133 | Present and future in the treatment of diabetic kidney disease |
| Q35763771 | Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus. |
| Q38764267 | TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook. |
| Q46470767 | Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice |
| Q45559795 | Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats |
| Q39969437 | Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis |
Search more.